Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...

Insulin glargine is a basal insulin ... While that is well below its peak of around $7 billion a year before biosimilars launched, the US has remained a stronghold for the brand because the ...

Some diabetes patients this year have had trouble finding their preferred insulin brands as major drug manufacturers reported shortages of the medicine. USA TODAY set out to find out what patients ...

Janel Wright had just days left in her insulin supply in early January when a pharmacist told her there was none of the drug left to fill her prescription. Her neighborhood Fred Meyer pharmacy in ...

We couldn’t be happier to see Dr Sheila Reith, CBE honoured at the Pride of Britain Awards for improving the lives of millions of people with diabetes worldwide.

A beloved former Stirling doctor, who transformed the lives of millions of people with diabetes after co-inventing the world’s first insulin pen, has been honoured with the Mirror Pride of ...

Peak oil has been a hot topic lately. Usually, it’s about demand and whether it would peak before 2030 or well after that. Sometimes, however, it’s about supply—and investment. Sometimes ...

Commentary on China’s place in the world tends to fall into two equally breathless camps. Is China an unstoppable economic, scientific, and military behemoth destined to dominate the shape of ...

Life with diabetes usually includes many injections of the blood sugar–controlling hormone insulin. Recent research investigating a once-weekly shot finds it might help lessen the burden a bit ...

Venture capital firm Peak XV Partners has unveiled its latest cohort comprising 14 startups from eight countries, including India, Australia, Singapore, the Philippines, China, UAE ...

Now, scientists have made a major breakthrough in developing what has been long called the “holy grail” diabetes treatments — a “smart” insulin that responds in real time to fluctuations in one’s ...